Liquid Biopsy-Based Biomarkers of Inflammatory Nociception Identified in Male Rats

Keyphrases

• Male Rats 100%
• Paw Inflammation 100%
• Liquid Biopsy 100%
• Inflammatory Nociception 100%
• Inflammatory Response 66%
• Behavioral Response 66%
• Chemokine (C-C motif) Ligand 2 (CCL2) 66%
• Inflammatory Pain 66%
• Matrix metalloproteinase-2 (MMP-2) 66%
• Locomotor Activity 66%
• Point-of-care 66%
• Matrix metalloproteinase-9 (MMP-9) 66%
• C-X-C Motif Chemokine Ligand 1 66%
• Inflammation 33%
• Injury Levels 33%
• Chemokines 33%
• Protein Expression 33%
• Clinical Care 33%
• Pain States 33%
• Pain Patients 33%
• Healthcare Settings 33%
• Activity Level 33%
• Pain Scale 33%
• Cytokine Levels 33%
• Matrix Metalloproteinases 33%
• Maximal Effect 33%
• Pain Sensation 33%
• Predictive Biomarker 33%
• Carrageenan-induced Inflammation 33%
• Paw Thickness 33%
• Subjective Pain 33%
• Locomotor Impairment 33%

Medicine and Dentistry

• Biological Marker 100%
• Nociception 100%
• Paw 100%
• Liquid Biopsy 100%
• Chemokine 50%
• Serositis 50%
• Inflammatory Pain 50%
• Gelatinase A 50%
• Gelatinase B 50%
• Lymphotactin 50%
• Cytokine 25%
• Protein Expression 25%
• Matrix Metalloproteinase 25%
• Intraplantar Drug Administration 25%
• Carrageenan 25%
• Pain Assessment 25%
• Gamma Chemokine 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Inflammation 100%
• Chemokine 33%
• Inflammatory Pain 33%
• Gelatinase A 33%
• Gelatinase B 33%
• Lymphotactin 33%
• Cytokine 16%
• Matrix Metalloproteinase 16%
• Carrageenan 16%
• Gamma Chemokine 16%